Status:
COMPLETED
Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation
Lead Sponsor:
Sohag University
Conditions:
Premature Ejaculation
Eligibility:
MALE
20-50 years
Phase:
PHASE3
Brief Summary
This study will aim to assess of the clinical efficacy and safety of dapoxetine, combined dapoxetine with folic acid and combined dapoxetine with vitamin B12 in treatment of patients with premature ej...
Detailed Description
In a single-blind placebo-controlled clinical study, it will be carried out on 120 patients with PE. All patients will be randomized equally divided into four groups (30 patients each). Group 1 was ...
Eligibility Criteria
Inclusion
- Premature ejaculation
Exclusion
- Erectile dysfunction
- Diabetes mellitus
- chronic prostatitis
- Advanced renal or hepatic diseases
- Neurological diseases
Key Trial Info
Start Date :
February 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04085354
Start Date
February 10 2019
End Date
August 29 2019
Last Update
September 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Sohag University, Egypt
Sohag, Egypt, 82524